|
Molecular cloning of Reteplase and its expression in E. coli using tac promoter
Safieh Aghaabdollahian1, Mohammad Rabbani1, Kamran Ghaedi2, Hamid Mir Mohammad Sadeghi1
1 Department of Pharmaceutical Biotechnology, Isfahan Pharmaceutical Science Research Center, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Biology, Faculty of Sciences, University of Isfahan, Isfahan, Iran
| Date of Submission | 25-Feb-2013 |
| Date of Acceptance | 17-Jun-2013 |
| Date of Web Publication | 12-Sep-2014 |
Correspondence Address:
Hamid Mir Mohammad Sadeghi
Department of Pharmaceutical Biotechnology and Isfahan Pharmaceutical Science Research Center, School of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan
Iran
 Source of Support: This research was supported by vice chancellor
of Research and Technology, Isfahan University of Medical Sciences,, Conflict of Interest: None  | Check |
DOI: 10.4103/2277-9175.140622
Background and Aims: This study aimed to clone and express the reteplase cDNA, a thrombolytic agent used for the treatment of acute myocardial infarction and stroke, in E. coli, utilizing tac promoter for its expression.
Materials and Methods: Reteplase cDNA was amplified by polymerase chain reaction (PCR) with designed primers. The product was then cloned into pTZ57R plasmid. The cloned cDNA was digested out and ligated into pGEX-5x-1 expression vector. The presence of the insert was confirmed by restriction digestion. By using 0.2, 0.5 and 1 mM isopropyl beta-D thiogalactopyranoside (IPTG), expression of reteplase was induced in E. coli TOP10 cells and analyzed by SDS-PAGE.
Results: Electrophoresis of PCR product and also double digested recombinant pTZ57R plasmid, also, pGEX-5x-1 vector, showed a 1068bp band of reteplase. SDS-PAGE analysis showed a 60 KDa band of protein product induced with different concentrations of IPTG.
Conclusion: In the present study, reteplase cDNA was successfully cloned and expressed using tac promoter. This vector will be used for the optimization of the expression of reteplase in E. coli. Keywords: Cloning, reteplase, t-PA, tac promoter
How to cite this article:
Aghaabdollahian S, Rabbani M, Ghaedi K, Sadeghi HM. Molecular cloning of Reteplase and its expression in E. coli using tac promoter
. Adv Biomed Res 2014;3:190 |
How to cite this URL:
Aghaabdollahian S, Rabbani M, Ghaedi K, Sadeghi HM. Molecular cloning of Reteplase and its expression in E. coli using tac promoter
. Adv Biomed Res [serial online] 2014 [cited 2023 Sep 28];3:190. Available from: https://www.advbiores.net/text.asp?2014/3/1/190/140622 |
| Introduction | |  |
Reteplase (recombinant plasminogen activator; r-PA) is one of the third generation thrombolytic agents that activates fibrin-bound plasminogen. [1],[2] It is used for the treatment of occlusive disorders, especially myocardial infarction which is responsible for more than 50% of cardiovascular events deaths. [3],[4],[5],[6] One of the important clinical advantages of t-PA is that it produces no side effects such as systemic hemorrhage and fibrinogen depletion and therefore many researchers are working towards the reduction of the cost of its production. [1],[2],[7] In comparison to tissue plasminogen activator (t-PA), reteplase is nonglycosylated and has longer half life. Reteplase is expressed in various bacterial, fungal, mammalian and insect systems. [4],[8],[9] However due to the variability of expression levels of r-PA in these systems, problems of protein instability and downstream processing, each expression system differs for its capabilities for the production of reteplase. Although the expression of r-PA in bacterial systems like E. coli has been investigated by some researchers, various cloning and expression plasmids and conditions can affect the yield and production characteristics of reteplase. One of the strongest promoters in E. coli is tac promoter, a hybrid of trp and lac promoters, [10],[11] which its efficacy is 2 to 3 times more than trp promoter and 7 times more than the lac UV5 promoter. It can be repressed by the lac repressor and can be induced with IPTG. [10],[12] Therefore, in this study we cloned and expressed r-PA gene in E. coli using tac promoter.[13]
| Materials and Methods | | |
Strains
E. coli XL1-blue , BL21 (DE3) and TOP 10 were obtained from Cinnagen, Iran.
Enzymes, primers, chemicals and plasmids
Restriction enzymes, modifying enzymes, SDS-PAGE reagents and other molecular related reagents were purchased from Fermentas, Poland. Primers for PCR reaction were purchased from Fanavarie Kowsar, Iran.
PCR Amplification and Cloning of r-PA cDNA
pETret , a recombinant plasmid containing reteplase cDNA (previously cloned in our laboratory), was used as template for PCR amplification. PCR was carried out with forward primer: 5CGG CGC GGA TCC CCA TGT CTT ACC AAG GAA ACA GTG ACT GCT AC 3 and reverse primer: 5GAA CCG CTC GAG TCA CGG TCG CAT GTT GTC ACG AAT CCA G 3 in a total volume of 50 μl containing 1.4 μl MgCl2, 1 μl of dNTP, 1 μl of each PCR primer, 5 μl 10x-PCR buffer, 0.4 μl of Taq polymerase enzyme and 1 μl of DNA template. Thermal cycles included initial denaturation at 94 ° C for 5 min followed by 30 cycles of 94 ° C for 1 min, 55 ° C for 2 min, and 72 ° C for 3 min; and one cycle of 72 ° C for 15 min. The purified PCR product was ligated into pTZ57R plasmid using Ins T/A clone kit (Fermentas, Poland) and transformed into E. coli XL1-blue cells using heat shock method. [14] Afterward, plasmid preparation was performed from the obtained colonies using Aurum plasmid mini kit (Roche, Germany) according to the manufacturer's instructions.
Construction of the recombinant expression vector
Recombinant pTZ57R plasmid (PTZ57R/ r-PA), and expression vector, pGEX-5x-1, were digested with BamHI and XhoI restriction enzymes and the obtained insert and pGEX-5x-1 vector were gel purified. Subsequently, reteplase cDNA was ligated to the pGEX-5x-1. Then this product was used for transformation of E. coli XL1-blue cells. The recombinant plasmids were then identified by restriction analysis and DNA sequencing.
Expression of reteplase in E. coli
The recombinant plasmid, pGEX-5x-1/ r-PA (rpGEX), was transformed in to competent E. coli strain TOP10 cells prepared using calcium chloride method. For negative control, pGEX-5x-1 plasmid was used for the transformation of TOP10 competent cells. Transformed cells were grown on LB agar plates supplemented with 100 mg/ml ampicillin (Roche, Germany) at 37°C. A single colony was inoculated into 5 ml LB medium. After overnight growth, 200 μl of the culture was transferred to the flasks containing 15 ml fresh LB medium and ampicillin. Additionally, 200 μl of the overnight culture of TOP10/pGEX-5x-1 and TOP10 without recombinant plasmid were transferred to the flasks containing 15 ml fresh LB medium containing antibiotic. Cells were shaken at 180 rpm to an OD 600 of 0.4-0.5, then over-expression of recombinant protein was induced by the addition of IPTG to the final concentrations of 0.2, 0.5, and 1 mM. The cultures were incubated further at 37°C. The OD 600 of these cultures were measured at intervals of 1 h for 4 h. Following each step, 1.5 ml of sample was taken and centrifuged at 4000 rpm. Pellets were resuspended in 100 μl of PBS (0.75 mMNa2HPO4, 0.1 mM NaCl, 1.7 mM KH2PO4, pH = 7.2) and 5 μl of SDS sample buffer (0.5
M Tris-HCl, pH=6.8, Glycerol, 10% SDS, 2.9 mM β-mercaptoethanol and 0.5% bromo-phenol blue) was added and then samples were heated at 90°C for 10 min. 20 μl of each sample was electrophoresed on a 12% SDS-polyacrylamide gel.
| Results | | |
The size of the PCR product was about 1068 bp which is the length of reteplase cDNA [Figure 1]. The reteplase cDNA was ligated into pTZ57R vector and was used for the transformation of E. coli XL1 blue cells. The obtained recombinant plasmids were then subjected to digestion with SacI restriction enzyme for the determination of the presence of reteplase cDNA in these plasmids. The observed 750 bp and 2850 bp bands confirmed the presence of reteplase [Figure 2].  | Figure 1: PCR amplification of reteplase cDNA (Lane 2, a = 1068 bp). Lane 1 shows 100 bp molecular weight marker. Lane 2: Arrow shows the band of the expected PCR product
Click here to view |
 | Figure 2: Digestion of reteplase cDNA with SacI restriction enzyme. Lane 1 shows 100 bp molecular weight marker, lane 2: Digested PCR product with SacI (a: 750 bp, b: 2850 bp)
Click here to view |
The recombinant pTZ57R plasmid was double digested with XhoI and BamHI restriction enzymes and the obtained insert was gel purified [Figure 3]. Additionally, pGEX-5x-1 plasmid was double digested with these enzymes. These were then ligated and used for the transformation of E. coli BL21 cells. Subsequently, the obtained recombinant pGEX-5x-1 plasmids were digested with XhoI and BamHI restriction enzymes to confirm the presence of the insert. Reteplase is a 39 KDa protein, but because of the presence of glutathione s-teransferase (gst) protein (25 KDa), an approximately 60 KDa protein was expressed. SDS-PAGE analysis of samples showed that target protein was induced with all IPTG concentrations [Figure 4]. | Figure 3: Digestion of pTZ57R/ reteplase with BamHI and XhoI restriction enzymes. Lane 1: Molecular weight marker, Lane 2: Digested recombinant plasmid containing reteplase cDNA (1068 bp)
Click here to view |
 | Figure 4: Induction of the expression of reteplase with different concentrations of IPTG 37°C. Proteins in the whole cell lysates were separated using SDS-PAGE. Lane 1: pGEX-5x-1 uninduced, Lane 2: pGEX-5x-1 induced for 2 h, Lane 3-6: rpGEX-5x-1- TOP10 induced with 1, 0.5, and 0.2 mM IPTG for 2 h respectively, Lane 7: rpGEX-5x-1- TOP10 induced with 1 mM IPTG for 4 h, Lane 8: Protein marker, Lane 9: TOP 10 bacteria at 37°C, Lane 10: rpGEX-5x-1- TOP10 uninduced. Arrow shows the 60kDa reteplase plus gst protein band
Click here to view |
| Discussion | | |
In this study we followed the aim of cloning and expression of reteplase in E. coli using tac promoter. In comparison to t-PA, reteplase is a single chain deletion mutant of t-PA [2],[4] containing 355 amino acid residues with molecular mass of 39 kDa. The Kringle II and Protease domains of t-PA is kept in reteplase and it retains enzymatic activity that is comparable to the native t-PA in vitro.[15] Reteplase has higher half life, lower adverse effects and easier administration. [2],[7] It is used for treating occlusive disorders of the lungs, heart, and brain. [3],[4],[5],[6] t-PA has been expressed in different systems such as bacteria, fungi, insect, yeasts, Chinese Hamster Ovary (CHO) and mammalian cell lines. [4],[8],[9],[16],[17] A problem occurring when mammalian cell lines are used is glycosylation of the product which leads to the rapid clearance of this drug. [1] Also because of wrong folding, low secretion to the culture media and high level of glycosylation, yeasts like Saccharomyces cervisiae and insect cells are unsuitable expression systems. [18],[19] Also, expression in CHO system could result in extraction complexity, and risk of viral infection. [20] Bacterial systems have many advantages such as lack of glycosylation, impaired receptor binding potential, fast cultivation, and low cost of downstream processing. [4] Liao et al., also have expressed reteplase in E. coli[21] but they have used a mutant sequence and a different cloning and expression vector as compared to our study (PMD18, pTZ57R cloning vectors, respectively). pTZ57R plasmid has an excess thymidine nucleotide at its 3'end and could be used for T/A cloning. [22],[23] This method is optional specially when we could not achieve suitable inserts for ligation. [23]
In the present study, we used pGEX-5x-1 expression vector which contains tac promoter. Tac promoter is a functional hybrid of the trp and the lac UV5 promoters. In this promoter the DNA upstream of position -20 with respect to the transcriptional start site is derived from the trp promoter and the DNA downstream of position -20 is derived from the lac UV5 promoter. Also it has a consensus pribnow box sequence in addition to a consensus -35 sequence. [10],[12] tac promoter is one of the strongest promoters in E. coli that have been characterized in vitro up to now. [11] Its efficacy is more than its parentral promoters and we could induce this promoter with IPTG. So this hybrid promoter is useful for the controlled expression of foreign genes at high levels in E. coli. [10],[24] pGEX-5x-1 expression vector includes GST sequence at the beginning of the insert. The pGEX GST fusion protein system is widely used for high level expression and rapid and efficient purification of fusion proteins expressed in bacterial lysates. [25],[26],[27] Also, this system has specific protease cleavage sites to facilitate proteolysis of the bacterial fusion proteins. [25] In a similar study, reteplase was expressed in E. coli TOP10 using pBAD/gIII expression vector. [28] This vector allows the product being transferred into the preplasmic space. However, the persiplasmic expression of reteplase was low and thus it seems that high levels of cytoplasmic expression of this enzyme would result in higher yields. Therefore, pGEX-5x-1 can be a better selection for expressing reteplase.
The results of our study showed expression of an approximately 60 KDa protein but in the other studies, [13],[21] a 39 KDa band was observed. This disagreement is because of the fusion of GST protein. Also, in the Gao et al, study, [15] an approximately 40 KDa protein band was expressed. This was due to the expression of a fusion protein consisting of hirudin-PA and reteplase. Also, Aflakiyan and etc observed a 45 KDa protein band because of post translational modifications occurred in the insect systems. [29]
| Conclusion | | |
In the present study we successfully cloned and expressed reteplase cDNA utilizing tac promoter. The induced vector can be used for future analysis of reteplase expression in E. coli.
| Acknowledgments | | |
This research was supported by vice chancellor of Research and Technology, Isfahan University of Medical Sciences and is a part of the Pharm. D thesis No 389383.
| References | | |
| 1. | Mattes R. The production of improved tissue-type plasminogen activator in Escherichia coli. Semin Thromb Hemost 2001;27:325-36. 
|
| 2. | Ellis K, Brener S. New fibrinolytic agents for MI: As effective as current agents, but easier to administer. Cleve Clin J Med 2004;71:20,3-5,9-30.
|
| 3. | Davami F, Sardari S, Majidzadeh AK, Hemayatkar M, Barkhordari F, Enayati S, et al. A novel variant of t-PA resistant to plasminogen activator inhibitor-1; Expression in CHO cells based on in silico experiments. BMB Rep 2011;44:34-9.
|
| 4. | Mandi N, Sundaram KR, Tandra SK, Bandyopadhyay S, Padmanabhan S. Asn and Asn: Critical residues for in vitro biological activity of reteplase. Adv Hematol 2010;2010:17284.
|
| 5. | Simpson D, Siddiqui Ma, Scott Lj, Hilleman DE. Spotlight on reteplase in thrombotic occlusive disorders. Bio Drugs 2007;21:65-86.
|
| 6. | Simpson D, Siddiqui MA, Scott LJ, Hilleman DE. Reteplase: A review of its use in the management of thrombotic occlusive disorders. Am J Cardiovasc Drugs 2006;6:265-85.
|
| 7. | Manosroi J, Tayapiwatana C, Gotz F, Werner RG, Manosroi A. Secretion of active recombinant human tissue plasminogen activator derivatives in Escherichia coli. Appl Environ Microbiol 2001;67:2657-64.
|
| 8. | Bass Sh, Yansura DG. Application of the E. coli trp promoter. Mol Biotechnol. 2000;16:253-60.
|
| 9. | Khan SR, Gaines J, Roop RM, Farrand SK. Broad-host-range expression vectors with tightly regulated promoters and their use to examine the influence of TraR and TraM expression on Ti plasmid quorum sensing. Appl Environ Microbiol 2008;74:5053-62.
|
| 10. | Boer H, Comstock LJ, Vasser M. The tac promoter: A functional hybrid derived from the trp and lac promoters. Proc Natl Acad Sci U S A 1983;80:21-5.
|
| 11. | Mulligan M, Brosius J, McClure WR. Characterization in vitro of the effect of spacer length on the activity of Escherichia coli RNA polymerase at the TAC promoter. J Biol Chem 1985;260:3529-38.
|
| 12. | Bagdasarian MM, Amann E, Lurz R, Ruckert B, Bagdasarian M. Activity of the hybrid trp-lac (tac) promoter of Escherichia coli in Pseudomonas putida. Construction of broad-host-range, controlled-expression vectors. Gene 1983;26:273-82.
|
| 13. | Sadeghi H, Rabbani M, Rismani E, Moazen F, Khodabakhsh F, Dormiani K, et al. Optimization of the expression of reteplase in Escherichia coli. Res Pharm Sci 2011;6:87-92.
|
| 14. | Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory; 1989.
|
| 15. | Gao L, Zhang C, Li L, Liang L, Deng X, Wu W, et al. Construction, expression and refolding of a bifunctional fusion protein consisting of C-terminal 12-residue of hirudin-PA and reteplase. Protein J 2012;31:328-36.
|
| 16. | Baruah DB, Dash RN, Chaudhari MR, Kadam SS. Plasminogen activators: A comparison. Vascu Pharmacol 2006;44:1-9.
|
| 17. | Rouf SA, Moo-Young M, Chisti Y. Tissue-type plasminogen activator: Characteristics, applications and production technology. Biotechnol Adv 1996;14:239-66.
|
| 18. | Ogrydziak DM. Yeast extracellular proteases. Crit Rev Biotechnol 1993;13:1-55.
|
| 19. | Furlong Am, Thomsen DR, Marotti KR, Post LE, Sharma SK. Active human tissue plasminogen activator secreted from insect cells using a baculovirus vector. Biotechnol Appl Biochem 1988;10:454-64.
|
| 20. | Griffiths Jb, Electricwala A. Production of tissue plasminogen activators from animal cells. Adv Biochem Eng Biotechnol 1987;34:147-66.
|
| 21. | Liao JZ, J. Shen Zl. Cloning and Expression of Tissue-Type Plasminogen Activator Mutant Reteplase(r-PA) in E. coli. Pharm Biotech 2002;9:94-8.
|
| 22. | Holton TA, Graham MW. A simple and efficient method for direct cloning of PCR products using ddT-tailed vectors. Nucleic Acids Res 1991;19:1156.
|
| 23. | Sadeghi HM, Ahmadi R, Aghaabdollahian S, Mofid MR, Ghaemi Y, Abedi D. Molecular cloning of gluconobacter oxydans DSM 2003 xylitol dehydrogenase gene. Res Pharm Sci 2011;6:51-5.
|
| 24. | Amann E, Brosius J, Ptashne M. Vectors bearing a hybrid trp-lac promoter useful for regulated expression of cloned genes in Escherichia coli. Gene 1983;25:167-78.
|
| 25. | Guan KL, Dixon JE. Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem 1991;192:262-7.
|
| 26. | Frangioni JV, Neel BG. Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Anal Biochem 1993;210:179-87.
|
| 27. | Smith DB, Johnson KS. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 1988;67:31-40.
|
| 28. | Khodabakhsh F, Moazen F, Mir Mohammad Sadeghi H, Rabbani M. Expression of reteplase in Escherichia coli top10 using arabinose Promoter. Res Pharm Sci 2012;7:S448.
|
| 29. | Aflakiyan S, Sadeghi HM, Shokrgozar M, Rabbani M, Bouzari S, Jahanian-Najafabadi A. Expression of the recombinant plasminogen activator (reteplase) by a non-lytic insect cell expression system. Res Pharm Sci 2013;8:9-15.
|
[Figure 1], [Figure 2], [Figure 3], [Figure 4]
| This article has been cited by | | 1 |
Incidence and Risk Factors of Dyslipidemia after Menopause |
|
| Ihn Sook Jeong, Hae Sun Yun, Myo Sung Kim, Youn Sun Hwang | | Journal of Korean Academy of Nursing. 2022; 52(2): 214 | | [Pubmed] | [DOI] | | | 2 |
Challenges to the Implementation of Interprofessional Education in Health Profession Education in Iran |
|
| Soleiman Ahmady,Zohrehsadat Mirmoghtadaie,Davood Rasouli | | Advances in Medical Education and Practice. 2020; Volume 11: 227 | | [Pubmed] | [DOI] | | | 3 |
Surfactants of microbial origin as antibiofilm agents |
|
| Katarzyna Paraszkiewicz,Magdalena Moryl,Grazyna Plaza,Diksha Bhagat,Surekha K. Satpute,Przemyslaw Bernat | | International Journal of Environmental Health Research. 2019; : 1 | | [Pubmed] | [DOI] | | | 4 |
Temporal trend analysis of stroke and salt intake: a 15-year population-based study |
|
| Shahram Arsang-Jang,Marjan Mansourian,Noushin Mohammadifard,Alireza Khosravi,Shahram Oveis-Gharan,Fatemeh Nouri,Nizal Sarrafzadegan | | Nutritional Neuroscience. 2019; : 1 | | [Pubmed] | [DOI] | | | 5 |
Efficient increase of the novel recombinant human plasminogen activator expression level and stability through the use of homozygote transgenic rabbits |
|
| Zhengyi He,Lei Jiang,Ting Zhang,Minya Zhou,Daijin Wu,Tingting Yuan,Yuguo Yuan,Yong Cheng | | International Journal of Molecular Medicine. 2018; | | [Pubmed] | [DOI] | | | 6 |
Efficient expression of cyclodextrin glycosyltransferase from Geobacillus stearothermophilus in Escherichia coli by promoter engineering and downstream box evolution |
|
| Chen Deng,Jianghua Li,Hyun-dong Shin,Guocheng Du,Jian Chen,Long Liu | | Journal of Biotechnology. 2018; 266: 77 | | [Pubmed] | [DOI] | | | 7 |
Evaluation of efficacy and safety of Reteplase and Alteplase in the treatment of hyper-acute cerebral infarction |
|
| Zhi-Jian Lin,Hong-Yan Qiu,Xiao-Xin Tong,Yi Guo,Man-Fu Han,Chun-Shui Yang,Kai-Hua Lin,Jun Wu,Xing Li,Yang Yang | | Bioscience Reports. 2018; 38(1) | | [Pubmed] | [DOI] | | | 8 |
A novel recombinant human plasminogen activator: Efficient expression and hereditary stability in transgenic goats and in vitro thrombolytic bioactivity in the milk of transgenic goats |
|
| Zhengyi He,Rui Lu,Ting Zhang,Lei Jiang,Minya Zhou,Daijin Wu,Yong Cheng,Juan J. Loor | | PLOS ONE. 2018; 13(8): e0201788 | | [Pubmed] | [DOI] | | | 9 |
Chromosome engineering of Escherichia coli for constitutive production of salvianic acid A |
|
| Liang Zhou,Qi Ding,Guo-Zhen Jiang,Zhen-Ning Liu,Hai-Yan Wang,Guang-Rong Zhao | | Microbial Cell Factories. 2017; 16(1) | | [Pubmed] | [DOI] | | | 10 |
High-level expression of a novel recombinant human plasminogen activator (rhPA) in the milk of transgenic rabbits and its thrombolytic bioactivity in vitro |
|
| Shaozheng Song,Xin Ge,Yaobin Cheng,Rui Lu,Ting Zhang,Baoli Yu,Xueqiao Ji,Zhengqiang Qi,Yao Rong,Yuguo Yuan,Yong Cheng | | Molecular Biology Reports. 2016; | | [Pubmed] | [DOI] | | | 11 |
Development of Escherichia coli Strain with Enhanced Enzymatic Activity of Acetyl Esterase Using a Strategy of Tandem Repetitive Promoters |
|
| Zhiwei Wu,Jing Chen,Zunhao Zhang,Lina Ma,Tianhui Xu,Haiye Yu,Qiang Zhang,Yuxiang Chen | | Waste and Biomass Valorization. 2016; | | [Pubmed] | [DOI] | | | 12 |
Overexpression of Escherichia coli Acetyl Esterase Using a Strategy of Multi-copy Promoters |
|
| Zhiwei Wu,Jing Chen,Zunhao Zhang,Lina Ma,Tianhui Xu,Haiye Yu,Qiang Zhang,Yuxiang Chen | | Waste and Biomass Valorization. 2016; | | [Pubmed] | [DOI] | |
|
 |
|
|
|
Search Pubmed for